AU2003226806A1 - Bicyclic heterocycles, medicaments containing these compounds, their use, and method for the production thereof - Google Patents
Bicyclic heterocycles, medicaments containing these compounds, their use, and method for the production thereofInfo
- Publication number
- AU2003226806A1 AU2003226806A1 AU2003226806A AU2003226806A AU2003226806A1 AU 2003226806 A1 AU2003226806 A1 AU 2003226806A1 AU 2003226806 A AU2003226806 A AU 2003226806A AU 2003226806 A AU2003226806 A AU 2003226806A AU 2003226806 A1 AU2003226806 A1 AU 2003226806A1
- Authority
- AU
- Australia
- Prior art keywords
- compounds
- production
- medicaments containing
- bicyclic heterocycles
- heterocycles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/08—Bridged systems
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10217689.2 | 2002-04-19 | ||
DE10217689A DE10217689A1 (en) | 2002-04-19 | 2002-04-19 | Bicyclic heterocycles, medicaments containing these compounds, their use and processes for their preparation |
PCT/EP2003/003828 WO2003089439A1 (en) | 2002-04-19 | 2003-04-14 | Bicyclic heterocycles, medicaments containing these compounds, their use, and method for the production thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003226806A1 true AU2003226806A1 (en) | 2003-11-03 |
Family
ID=29224623
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003226806A Abandoned AU2003226806A1 (en) | 2002-04-19 | 2003-04-14 | Bicyclic heterocycles, medicaments containing these compounds, their use, and method for the production thereof |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1499619A1 (en) |
JP (1) | JP4527406B2 (en) |
AR (1) | AR039571A1 (en) |
AU (1) | AU2003226806A1 (en) |
CA (1) | CA2484395C (en) |
DE (1) | DE10217689A1 (en) |
PE (1) | PE20040171A1 (en) |
TW (1) | TW200408643A (en) |
UY (1) | UY27767A1 (en) |
WO (1) | WO2003089439A1 (en) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA01012899A (en) | 1999-06-21 | 2002-07-30 | Boehringer Ingelheim Pharma | Bicyclic heterocycles, medicaments containing these compounds, their use and methods for the production thereof. |
US7019012B2 (en) | 2000-12-20 | 2006-03-28 | Boehringer Ingelheim International Pharma Gmbh & Co. Kg | Quinazoline derivatives and pharmaceutical compositions containing them |
US20040044014A1 (en) | 2002-04-19 | 2004-03-04 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof |
EP2277867B1 (en) | 2002-07-15 | 2012-12-05 | Symphony Evolution, Inc. | Compounds, pharmaceutical compositions thereof and their use in treating cancer |
WO2006074147A2 (en) | 2005-01-03 | 2006-07-13 | Myriad Genetics, Inc. | Nitrogen containing bicyclic compounds and therapeutical use thereof |
US8309562B2 (en) | 2003-07-03 | 2012-11-13 | Myrexis, Inc. | Compounds and therapeutical use thereof |
EP2609919A3 (en) | 2003-09-26 | 2014-02-26 | Exelixis, Inc. | c-Met modulators and methods of use |
KR20080095915A (en) * | 2004-05-06 | 2008-10-29 | 워너-램버트 캄파니 엘엘씨 | 4-phenylamino-quinazolin-6-yl-amides |
US8258145B2 (en) | 2005-01-03 | 2012-09-04 | Myrexis, Inc. | Method of treating brain cancer |
KR100832593B1 (en) * | 2005-11-08 | 2008-05-27 | 한미약품 주식회사 | Quinazoline derivatives as an signal trnasduction inhibitor and method for the preparation thereof |
WO2007054550A1 (en) | 2005-11-11 | 2007-05-18 | Boehringer Ingelheim International Gmbh | Quinazoline derivatives for the treatment of cancer diseases |
EP2068880B1 (en) | 2006-09-18 | 2012-04-11 | Boehringer Ingelheim International GmbH | Method for treating cancer harboring egfr mutations |
TWI577664B (en) | 2009-01-16 | 2017-04-11 | 艾克塞里克斯公司 | Malate salt of n-(4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, pharmaceutical composition comprising the same and use thereof |
WO2011002523A1 (en) | 2009-07-02 | 2011-01-06 | Kanionusa Inc. | Phosphorus containing quinazoline compounds and methods of use |
EP2451445B1 (en) | 2009-07-06 | 2019-04-03 | Boehringer Ingelheim International GmbH | Process for drying of bibw2992, of its salts and of solid pharmaceutical formulations comprising this active ingredient |
UA108618C2 (en) | 2009-08-07 | 2015-05-25 | APPLICATION OF C-MET-MODULATORS IN COMBINATION WITH THEMOSOLOMID AND / OR RADIATION THERAPY FOR CANCER TREATMENT | |
CN102020639A (en) * | 2009-09-14 | 2011-04-20 | 上海恒瑞医药有限公司 | 6-amido quinazoline or 3-cyano quinoline derivative, preparation method thereof and application of derivative to medicament |
HUE033575T2 (en) * | 2011-05-26 | 2017-12-28 | Xuanzhu Pharma Co Ltd | Quinazoline derivative as tyrosine-kinase inhibitor, preparation method therefor and application thereof |
KR20140093223A (en) * | 2011-10-12 | 2014-07-25 | 텔리진 엘티디. | Quinazoline derivatives as kinases inhibitors and methods of use thereof |
US9242965B2 (en) | 2013-12-31 | 2016-01-26 | Boehringer Ingelheim International Gmbh | Process for the manufacture of (E)-4-N,N-dialkylamino crotonic acid in HX salt form and use thereof for synthesis of EGFR tyrosine kinase inhibitors |
WO2020068867A1 (en) | 2018-09-25 | 2020-04-02 | Black Diamond Therapeutics, Inc. | Quinazoline derivatives as tyrosine kinase inhibitor, compositions, methods of making them and their use |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR9708640B1 (en) * | 1996-04-12 | 2013-06-11 | irreversible tyrosine kinase inhibitors and pharmaceutical composition comprising them. | |
TW436485B (en) * | 1997-08-01 | 2001-05-28 | American Cyanamid Co | Substituted quinazoline derivatives |
BRPI9914164B8 (en) * | 1998-09-29 | 2021-05-25 | American Cyanamid Co | 3-cyano quinoline compounds |
SK12112001A3 (en) * | 1999-02-27 | 2001-12-03 | Boehringer Ingelheim Pharma Kg | 4-amino-quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases |
DE19908567A1 (en) * | 1999-02-27 | 2000-08-31 | Boehringer Ingelheim Pharma | New 4-amino-quinazoline or quinoline derivatives, are tyrosine kinase-mediated signal transduction inhibitors useful e.g. for treating tumors, polyps or respiratory or gastrointestinal diseases |
MXPA01012899A (en) * | 1999-06-21 | 2002-07-30 | Boehringer Ingelheim Pharma | Bicyclic heterocycles, medicaments containing these compounds, their use and methods for the production thereof. |
AU6383101A (en) * | 2000-04-08 | 2001-10-23 | Boehringer Ingelheim Pharma Kg | Bicyclic heterocylces, medicaments containing said compounds, the use thereof and method for producing them |
DE10017539A1 (en) * | 2000-04-08 | 2001-10-11 | Boehringer Ingelheim Pharma | New 6-acylamino-4-amino-quinazoline or quinoline derivatives, are tyrosine kinase-mediated signal transduction inhibitors useful e.g. for treating tumors or respiratory or gastrointestinal diseases |
DE10042062A1 (en) * | 2000-08-26 | 2002-03-07 | Boehringer Ingelheim Pharma | Bicyclic heterocycles, medicaments containing these compounds, their use and methods of preparation |
DE10042061A1 (en) * | 2000-08-26 | 2002-03-07 | Boehringer Ingelheim Pharma | Bicyclic heterocycles, medicaments containing these compounds, their use and processes for their preparation |
-
2002
- 2002-04-19 DE DE10217689A patent/DE10217689A1/en not_active Withdrawn
-
2003
- 2003-04-14 CA CA2484395A patent/CA2484395C/en not_active Expired - Fee Related
- 2003-04-14 AU AU2003226806A patent/AU2003226806A1/en not_active Abandoned
- 2003-04-14 WO PCT/EP2003/003828 patent/WO2003089439A1/en active Application Filing
- 2003-04-14 JP JP2003586159A patent/JP4527406B2/en not_active Expired - Fee Related
- 2003-04-14 EP EP03746824A patent/EP1499619A1/en not_active Withdrawn
- 2003-04-15 PE PE2003000384A patent/PE20040171A1/en not_active Application Discontinuation
- 2003-04-16 AR ARP030101330A patent/AR039571A1/en not_active Withdrawn
- 2003-04-16 UY UY27767A patent/UY27767A1/en not_active Application Discontinuation
- 2003-04-16 TW TW092108807A patent/TW200408643A/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2484395C (en) | 2011-11-22 |
JP2005526837A (en) | 2005-09-08 |
AR039571A1 (en) | 2005-02-23 |
UY27767A1 (en) | 2003-11-28 |
CA2484395A1 (en) | 2003-10-30 |
PE20040171A1 (en) | 2004-06-02 |
EP1499619A1 (en) | 2005-01-26 |
DE10217689A1 (en) | 2003-11-13 |
JP4527406B2 (en) | 2010-08-18 |
TW200408643A (en) | 2004-06-01 |
WO2003089439A1 (en) | 2003-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001295481A1 (en) | Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof | |
AU2001287694A1 (en) | Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof | |
AU2003257465A1 (en) | Substituted diaryl heterocycles, method for the production and use thereof as medicaments | |
IL147133A0 (en) | Bicyclic heterocycles, medicaments containing these compounds, their use and methods for the production thereof | |
HUP0300819A3 (en) | Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof | |
AU6383101A (en) | Bicyclic heterocylces, medicaments containing said compounds, the use thereof and method for producing them | |
AU2002219173A1 (en) | Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use | |
AU2003226806A1 (en) | Bicyclic heterocycles, medicaments containing these compounds, their use, and method for the production thereof | |
AU2002231688A1 (en) | Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use | |
AU2003282094A1 (en) | Novel dihydroxy-methylphenyl derivatives, method for the production and use thereof as medicaments | |
HK1081965A1 (en) | Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same | |
IL156552A0 (en) | Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use | |
IL191926A0 (en) | Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof | |
HUP0401329A2 (en) | Aminoalkyl-substituted aromatic bicyclic compounds, method for the production thereof and their use as medicaments | |
IL191988A0 (en) | Bicyclic heterocycles, medicaments containing said compounds, use thereof, and method for the production thereof | |
AU2003206760A1 (en) | Anticholinergic agents, method for producing the same and use thereof as medicaments | |
HK1090042A1 (en) | Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the of the same as medicaments, and medicament containing such compounds | |
AU2001289814A1 (en) | Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof | |
AU2001284021A1 (en) | Quinazoline derivatives, medicaments containing these compounds, their use, and methods for the production thereof | |
HRP20041203A2 (en) | Ring-substituted diphenyl azetidinones, method for the production thereof, medicaments containing said compounds, and use thereof | |
AU2003271185A1 (en) | Imidazopyridine derivative, process for producing the same, and use | |
AU2003250753A1 (en) | Method for producing organic compounds containing poly-dopo, and the use of the same | |
AU2003255450A1 (en) | Polyolefin multilayered film, method for the production of said film and use thereof | |
AU2003229863A1 (en) | Porphyrin derivatives, method for the production thereof, pharmaceutical compositions and use thereof | |
AU2003216893A1 (en) | Phenethylacrylamide, methods for the production thereof and agents containing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |